Venlafaxine

Venlafaxine (CAS No.: 93413-69-5) is an arylalkanolamine compound classified as a selective serotonin and norepinephrine reuptake inhibitor (SNRI). By inhibiting the reuptake of serotonin (5-HT) and norepinephrine (NE), it plays a key role in the regulation of neurotransmitter systems. This compound is widely recognized in biomedical research for its ability to influence neurotransmitter pathways, enhancing synaptic concentrations and thereby altering neuronal communication. Research applications of Venlafaxine mainly focus on elucidating mechanisms of mood regulation, anxiety, and stress responses, typically using various cellular and animal models. Although specific IC50 or EC50 values for its inhibition of neurotransmitter transporters have not been clearly reported, it generally demonstrates activity in the nanomolar to micromolar range, which is common for potent reuptake inhibitors. The design of research experiments often varies widely, with concentrations determined according to specific study objectives, whether for detailed mechanistic studies or broad screening of potential neurochemical pathway modulation. Leveraging its pharmacological properties, researchers aim to deepen the understanding of psychiatric disorders and facilitate exploration of neurotransmitter interactions in cellular and animal models.